Please view the 2023 RPTH State-of-the-Art Illustrated Capsules here.
Learning Objectives:
describe recent progress in biobank-scale genomics of stroke (especially ischemic stroke) and covert MRI-markers of cerebral small vessel disease
visualize how large-scale genetic associations for cerebrovascular disease can be leveraged for genomics-driven drug discovery, and how this is relevant to anti-thrombotic treatments
differentiate subtypes of cerebrovascular disease and their respective relation with thrombotic mechanisms, again through insights from genomics